Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Alnylam Pharmaceuticals Inc (ALNY)  
$151.22 3.82 (2.59%) as of 4:30 Thu 5/16


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 123,030,000
Market Cap: 18.60(B)
Last Volume: 934,860 Avg Vol: 724,527
52 Week Range: $143.31 - $211.65
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  824
Guru Rank Value     : 0.5
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company developing therapeutics based on RNA interference. Co. has four RNAi-based medicines, ONPATTRO® (patisiran), GIVLAARI® (givosiran), OXLUMO™ (lumasiran) and Leqvio® (inclisiran). ONPATTRO is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. GIVLAARI is approved for the treatment of adults with acute hepatic porphyria. Co. has approval for OXLUMO for the treatment of hyperoxaluria type 1 (PH1) in all age groups. Leqvio (inclisiran) is being developed for the treatment of adults with hypercholesterolemia or mixed dyslipidemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 45,264 76,855 102,504 247,093
Total Sell Value $6,835,665 $12,957,715 $17,713,340 $48,829,179
Total People Sold 6 7 8 9
Total Sell Transactions 10 12 18 35
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 746
  Page 18 of 30  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Maraganore John Chief Executive Officer   •       •      –    2014-12-15 4 OE $9.14 $74,994 D/D 8,205 112,825     -
   Mason Michael VP, Finance and Treasurer   •       –      –    2014-12-15 4 AS $95.10 $2,160,808 D/D (22,162) 0     -
   Mason Michael VP, Finance and Treasurer   •       –      –    2014-12-15 4 OE $7.10 $237,117 D/D 20,625 22,162     -
   Schimmel Paul Director   –       •      –    2014-12-08 4 AS $105.00 $1,575,000 D/D (15,000) 0     -
   Schimmel Paul Director   –       •      –    2014-12-08 4 OE $22.09 $331,350 D/D 15,000 15,000     -
   Ausiello Dennis A Director   –       •      –    2014-12-08 4 AS $105.00 $1,625,000 D/D (15,000) 13,165     -
   Ausiello Dennis A Director   –       •      –    2014-12-08 4 OE $30.09 $451,350 D/D 15,000 28,165     -
   Reid Laurence SVP, Chief Business Officer   •       –      –    2014-11-18 4 AS $90.30 $906,670 D/D (10,000) 3,905     -
   Reid Laurence SVP, Chief Business Officer   •       –      –    2014-11-18 4 OE $7.10 $111,227 D/D 10,000 13,905     -
   Greene Barry E President and COO   •       –      –    2014-11-17 4 AS $89.11 $2,975,780 D/D (33,200) 33,592     -
   Greene Barry E President and COO   •       –      –    2014-11-17 4 OE $6.78 $225,096 D/D 33,200 66,792     -
   Greene Barry E President and COO   •       –      –    2014-11-11 4 AS $100.00 $1,110,000 D/D (11,100) 33,592     -
   Greene Barry E President and COO   •       –      –    2014-11-11 4 OE $6.78 $75,258 D/D 11,100 44,692     -
   Ausiello Dennis A Director   –       •      –    2014-11-11 4 AS $100.00 $500,000 D/D (5,000) 13,165     -
   Ausiello Dennis A Director   –       •      –    2014-11-11 4 OE $30.09 $150,450 D/D 5,000 18,165     -
   Schimmel Paul Director   –       •      –    2014-10-28 4 AS $95.00 $1,425,000 D/D (15,000) 0     -
   Schimmel Paul Director   –       •      –    2014-10-28 4 OE $15.91 $238,650 D/D 15,000 15,000     -
   Ausiello Dennis A Director   –       •      –    2014-10-22 4 AS $90.00 $450,000 D/D (5,000) 13,165     -
   Ausiello Dennis A Director   –       •      –    2014-10-22 4 OE $30.09 $150,450 D/D 5,000 18,165     -
   Sharp Philip A Director   –       •      –    2014-10-13 4 AS $85.00 $9,350,000 D/D (110,000) 74,996     -
   Sharp Philip A Director   –       •      –    2014-10-13 4 OE $7.08 $847,800 D/D 110,000 184,996     -
   Starr Kevin P Director   –       •      –    2014-09-25 4 AS $76.36 $3,469,881 D/D (45,000) 0     -
   Starr Kevin P Director   –       •      –    2014-09-25 4 OE $14.74 $988,500 D/D 45,000 45,000     -
   Starr Kevin P Director   –       •      –    2014-09-24 4 AS $77.48 $3,558,557 D/D (45,000) 0     -
   Starr Kevin P Director   –       •      –    2014-09-24 4 OE $7.08 $527,650 D/D 45,000 45,000     -
  746 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 18 of 30
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us